Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03765-8Source: DataRank Database

A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy is a research paper published in Cancer Immunology Immunotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.93)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (26)

Michael J. Dee ORCID,Pallavi Chaturvedi,Gilles M. Leclerc ORCID,Mary Mathyer,Celeste Dufour

Live enrichment

PubMed:38960949 PMC:PMC11222348 OpenAlex:https://openalex.org/W4400280112

NIH

Grant: P50CA171963

NCI NIH HHS

Grant: P30 CA091842

National Institutes of Health

Grant: 5R01CA205239-02

TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY

National Institutes of Health

Grant: 5P50CA171963-09

Specialized Program Of Research Excellence (SPORE) in Leukemia.

National Institutes of Health

Grant: 5P30CA091842-05

Core--Pharmacology Facility

Wugen

Paula C and Rodger O. Riney Blood Cancer Initiative

HCW Biologics

FWCI

0.93

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00262-024-03765-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-024-03765-8.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-024-03765-8/fulltext.html

journalhttps://doi.org/10.1007/s00262-024-03765-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38960949

Fields of Study

Immune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansImmunologic MemoryKiller Cells, NaturalRecombinant Fusion ProteinsImmunotherapy, AdoptiveInterleukin-15MiceCell- and Tissue-Based Therapy

Keywords

Priming (agriculture)Ex vivoImmunologyImmunotherapyBiologyCell biologyImmune systemCancer researchIn vitroBiochemistryNK cellsAdoptive Cell TherapyCytokine-induced Memory Like Nk Cells, Il-7, il-12, Il-15, Il-18, Il-21Prime And ExpandKiller Cells, NaturalInterleukin-15MiceResearchRecombinant Fusion ProteinsCell- and Tissue-Based TherapyHumansAnimalsImmunologic MemoryImmunotherapy, Adoptive

Sustainable Development Goals

SDG 0: Good health and well-being